CERS
Cerus Corporation
Company Overview
| Mkt Cap | $279.88M | Price | $1.47 |
| Volume | 1.29M | Change | +5.00% |
| P/E Ratio | -13.4 | Open | $1.40 |
| Revenue | $201.3M | Prev Close | $1.40 |
| Net Income | $-20.9M | 52W Range | $1.12 - $2.24 |
| Div Yield | N/A | Target | $4.67 |
| Overall | 55 | Value | 55 |
| Quality | 57 | Technical | 54 |
No chart data available
Stock Overview
Updated DailyCerus Corporation (CERS) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.47 with a market capitalization of $279.88 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CERS with a volume of 1.29 million shares. The stock opened down 0.00% from yesterday's close of $1.40. Current analyst estimates project earnings of $-0.12 per share for this year, with next year targeting $-0.05.
CERS demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including HAE, BTX, BSX, UTMD.
Key investment considerations for CERS include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 217.7%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 04:25 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CERS | $1.47 | +5.0% | 1.29M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |